Abstract
Antibodies to the N‐methyl‐D‐aspartate receptor have been recently described in psychiatric patients in the last decade, but uncertainty as to whom should be tested is common. Here, the authors describe the clinical characteristics of patients who have been tested over five years in a psychiatric hospital, and compare this with the current literature.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
